CAMILLE FRANCA: Open Payments
NPI 1083470470 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,320 in 60 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $818 · 2025 $1,320
Food & beverage: $1,320
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $233 |
| AstraZeneca Pharmaceuticals LP | 8 | $181 |
| ABBVIE INC. | 9 | $180 |
| Boston Scientific Corporation | 1 | $149 |
| Lilly USA, LLC | 9 | $137 |
| Novo Nordisk Inc | 4 | $77 |
| Saluda Medical Americas, Inc. | 3 | $63 |
| Exact Sciences Corporation | 3 | $56 |
| SANOFI-AVENTIS U.S. LLC | 3 | $54 |
| PFIZER INC. | 2 | $43 |
Products named: WATCHMAN FLX, REPATHA, MOUNJARO, UBRELVY, FARXIGA, AIRSUPRA, Evoke, LINZESS.
Industry payments across FL — which companies pay providers there.
